"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"

PHASE2TerminatedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

March 24, 2025

Study Completion Date

March 24, 2025

Conditions
Musculoskeletal DiseasesSoft Tissue Mass
Interventions
DRUG

Exparel Injectable Product

Both drugs have same desired effect. Will be injected intra-operatively while subjects are under anesthesia to alleviate significant post-operative pain.

DRUG

Multi-Drug Cocktail (Ropivicaine, Epinephrine, Ketolorac, Clonidine)

Same desired effect as Exparel but different mechanism of action. Will be injected intra-operatively while subjects are under anesthesia to alleviate significant post-operative pain.

Trial Locations (1)

07960

Morristown Medical Center, Morristown

Sponsors
All Listed Sponsors
lead

Atlantic Health System

OTHER

NCT05355597 - "The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors" | Biotech Hunter | Biotech Hunter